Rabinowich H, Cohen R, Bruderman I, Steiner Z, Klajman A
Cancer Res. 1987 Jan 1;47(1):173-7.
Lymphocytes separated from surgically resected tumor tissue, uninvolved lung tissue, and peripheral blood of lung cancer patients were investigated for cytotoxic potential and analyzed for their phenotypes at the time of surgery and after having been propagated for 4 to 5 wk in the presence of interleukin-2. Most of the tumor lymphocyte infiltrates examined were shown to have a shift in favor of T8 subsets from those found in peripheral blood. No natural killer activity and low cytotoxicity against the autologous tumor were found to characterize the tumor-derived lymphocyte population. Propagation of lymphocytes from the different tissues of the cancer patient in the presence of interleukin-2 preparation induced widespread lytic activity against K562 cells, autologous and allogeneic tumors, but not autologous normal lung or lymphoblasts. However, cytotoxic activity against autologous tumor cells exerted by cultured tumor-infiltrating lymphocytes was found to be significantly higher than the activity of cultured lymphocytes isolated from peripheral blood or uninvolved lung tissue of the same patient. The elevated lytic activity of cells derived from the tumor tissue indicates the accumulation at the tumor site of precursors of natural killer-like cells and specifically stimulated antitumor effectors. Our results suggest the coexistence of two types of anti-autotumor cytotoxic lymphocytes at the tumor site: natural killer-like and specific cytotoxic T-cells.
对从肺癌患者手术切除的肿瘤组织、未受累肺组织及外周血中分离出的淋巴细胞进行了细胞毒性潜能研究,并在手术时及在白细胞介素-2存在下培养4至5周后分析了它们的表型。结果显示,所检测的大多数肿瘤淋巴细胞浸润物与外周血中的相比,T8亚群占比增加。肿瘤来源的淋巴细胞群体的特征是无自然杀伤活性,对自体肿瘤的细胞毒性较低。在白细胞介素-2制剂存在下培养癌症患者不同组织中的淋巴细胞,可诱导其对K562细胞、自体和异体肿瘤产生广泛的溶解活性,但对自体正常肺组织或淋巴母细胞无此活性。然而,发现培养的肿瘤浸润淋巴细胞对自体肿瘤细胞的细胞毒性活性明显高于从同一患者外周血或未受累肺组织中分离出的培养淋巴细胞的活性。肿瘤组织来源细胞的溶解活性升高表明自然杀伤样细胞前体和特异性刺激的抗肿瘤效应细胞在肿瘤部位积聚。我们的结果表明,肿瘤部位存在两种抗自体肿瘤细胞毒性淋巴细胞:自然杀伤样细胞和特异性细胞毒性T细胞。